Table 2.
Clinical and disease-related characteristics of HIV/AIDS-infected children who had follow-up at ART centres of Gedeo public hospitals, Southern Ethiopia, 2020 (N=254)
| Covariates | Category | Outcome status | Total (%) | |
| Attrition (%) | Censored (%) | |||
| Developmental status (<5 years) | Appropriate | 32 (36) | 57 (64) | 89 (87.2) |
| Delayed | 10 (76.9) | 3 (23.1) | 13 (12.8) | |
| Functional status (>5 years) | Working | 25 (29.8) | 59 (70.2) | 84 (55.3) |
| Ambulatory | 18 (30.5) | 41 (69.5) | 59 (38.8) | |
| Bedridden | 7 (77.8) | 2 (22.2) | 9 (5.9) | |
| WFA | Z-score >−2 | 72 (32.1) | 152 (67.9) | 224 (88.2) |
| Z-score ≤−2 | 20 (66.7) | 10 (33.3) | 30 (11.8) | |
| HFA | Z-score >−2 | 75 (32.8) | 154 (67.2) | 229 (90.2) |
| Z-score ≤−2 | 17 (68) | 8 (32) | 25 (9.8) | |
| Baseline haemoglobin | <10 mg/dL | 51 (68.9) | 23 (31.1) | 74 (29.1) |
| ≥10 mg/dL | 41 (22.8) | 139 (77.2) | 180 (70.9) | |
| Baseline CD4+ count | ≤200 | 23 (65.7) | 12 (34.3) | 35 (13.8) |
| >200–350 | 24 (55.8) | 19 (44.2) | 43 (16.9) | |
| ≥350 | 45 (25.6) | 131 (74.4) | 176 (69.3) | |
| WHO clinical stage | I and II | 53 (30.5) | 121 (69.5) | 174 (68.5) |
| III and IV | 39 (48.8) | 41 (51.2) | 80 (31.5) | |
| Disclosure status | Disclosed | 52 (34.4) | 99 (65.6) | 151 (59.45) |
| Not disclosed | 40 (38.8) | 63 (61.2) | 103 (40.55) | |
| Opportunistic infections | No | 66 (33.2) | 133 (66.8) | 199 (78.35) |
| Yes | 26 (47.3) | 29 (52.7) | 55 (21.65) | |
| Tuberculosis | No | 82 (35.2) | 151 (64.8) | 233 (91.7) |
| Yes | 10 (47.6) | 11 (52.4) | 21 (8.3) | |
ART, antiretroviral treatment; HFA, height-for-age; WFA, weight-for-age.